Question 1

What are the top holdings in PBE?

Accepted Answer

Invesco Biotechnology & Genome ETF (PBE) holds 33 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.

Question 2

How concentrated is PBE's portfolio?

Accepted Answer

Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review PBE's holdings table to analyze concentration risk.

Question 3

What is PBE's sector allocation?

Accepted Answer

The Sector Allocation chart shows how PBE distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.

Question 4

What countries does PBE invest in?

Accepted Answer

PBE's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.

Question 5

How diversified is PBE ETF?

Accepted Answer

PBE's diversification can be assessed by reviewing its 33 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.

Question 6

What are PBE's largest positions by weight?

Accepted Answer

PBE's largest positions are listed in the holdings table, sorted by portfolio weight percentage. The top holdings represent the securities with the highest allocation in the fund's portfolio composition.

#	Symbol	Name	Type	Weight
1	GILD	Gilead Sciences, Inc.	Stock	5.89%
2	AMGN	Amgen Inc.	Stock	5.43%
3	ILMN	Illumina, Inc.	Stock	5.24%
4	BIIB	Biogen Inc.	Stock	5.18%
5	UTHR	United Therapeutics Corporation	Stock	5.08%
6	ALNY	Alnylam Pharmaceuticals, Inc	Stock	5.01%
7	REGN	Regeneron Pharmaceuticals, Inc.	Stock	4.97%
8	INCY	Incyte Corporation	Stock	4.78%
9	FOLD	Amicus Therapeutics, Inc.	Stock	3.89%
10	DVAX	Dynavax Technologies Corporation	Stock	3.65%
11	BCRX	BioCryst Pharmaceuticals Inc	Stock	3.11%
12	ACAD	ACADIA Pharmaceuticals Inc	Stock	3.09%
13	MNKD	MannKind Corp	Stock	3.03%
14	NBIX	Neurocrine Biosciences, Inc	Stock	3.02%
15	RPRX	Royalty Pharma plc	Stock	2.99%
16	QGEN	Qiagen N.V.	Stock	2.92%
17	COLL	Collegium Pharmaceutical Inc	Stock	2.90%
18	IONS	Ionis Pharmaceuticals, Inc	Stock	2.86%
19	HALO	Halozyme Therapeutics, Inc.	Stock	2.86%
20	PTGX	Protagonist Therapeutics Inc	Stock	2.84%
21	TECH	Bio-Techne Corporation	Stock	2.79%
22	BMRN	BioMarin Pharmaceutical Inc.	Stock	2.77%
23	EXEL	Exelixis, Inc	Stock	2.75%
24	CPRX	Catalyst Pharmaceuticals, Inc.	Stock	2.74%
25	MDGL	Madrigal Pharmaceuticals, Inc	Stock	2.67%
26	PTCT	PTC Therapeutics, Inc	Stock	2.65%
27	TGTX	TG Therapeutics, Inc	Stock	2.65%
28	RGEN	Repligen Corporation	Stock	2.65%
29	VCEL	Vericel Corporation	Stock	2.64%
30	VCYT	Veracyte, Inc	Stock	2.62%
31	N NMFQS:AGPXX	Short-Term Investment Trust - Invesco Government & Agency Portfolio	Cash	0.09%

PBE ETF Holdings: Invesco Biotechnology & Genome ETF

Portfolio Allocations

Top 31 Holdings by Portfolio Weight